These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 28778498)

  • 1. Prognostic role of Nectin-4 expression in luminal B (HER2 negative) breast cancer.
    Rajc J; Gugić D; Fröhlich I; Marjanović K; Dumenčić B
    Pathol Res Pract; 2017 Sep; 213(9):1102-1108. PubMed ID: 28778498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Nectin-4 in Chromophobe Renal Cell Carcinoma in a Multicenter Cohort: Early Prognostic and Therapeutic Considerations.
    Mikuteit M; Zschäbitz S; Autenrieth M; Weichert W; Hartmann A; Steffens S; Erlmeier F
    Oncology; 2024; 102(6):503-509. PubMed ID: 38043528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy.
    Chatterjee S; Sinha S; Kundu CN
    Eur J Pharmacol; 2021 Nov; 911():174516. PubMed ID: 34547246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation Between Luminal-A and Luminal-B Breast Cancer Using Intravoxel Incoherent Motion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Kawashima H; Miyati T; Ohno N; Ohno M; Inokuchi M; Ikeda H; Gabata T
    Acad Radiol; 2017 Dec; 24(12):1575-1581. PubMed ID: 28778511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High expression of Nectin-4 is associated with unfavorable prognosis in gastric cancer.
    Zhang Y; Zhang J; Shen Q; Yin W; Huang H; Liu Y; Ni Q
    Oncol Lett; 2018 Jun; 15(6):8789-8795. PubMed ID: 29805618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer.
    Zeindler J; Soysal SD; Piscuoglio S; Ng CKY; Mechera R; Isaak A; Weber WP; Muenst S; Kurzeder C
    Front Med (Lausanne); 2019; 6():200. PubMed ID: 31572728
    [No Abstract]   [Full Text] [Related]  

  • 7. The Prognostic Role of Expression of Nectin-4 in Esophageal Cancer.
    Lin X; Hu H; Pan Y; Gao S
    Med Sci Monit; 2019 Dec; 25():10089-10094. PubMed ID: 31883369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of Nectin-4 promotes progression of esophageal cancer and correlates with poor prognosis of the patients.
    Deng H; Shi H; Chen L; Zhou Y; Jiang J
    Cancer Cell Int; 2019; 19():106. PubMed ID: 31043861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of Nectin-4 and PD-L1 in Upper Tract Urothelial Carcinoma.
    Tomiyama E; Fujita K; Rodriguez Pena MDC; Taheri D; Banno E; Kato T; Hatano K; Kawashima A; Ujike T; Uemura M; Takao T; Yamaguchi S; Fushimi H; Yoshimura K; Uemura H; Netto GJ; Nonomura N
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant SLAMblind Measles Virus Is a Promising Candidate for Nectin-4-Positive Triple Negative Breast Cancer Therapy.
    Fujiyuki T; Amagai Y; Shoji K; Kuraishi T; Sugai A; Awano M; Sato H; Hattori S; Yoneda M; Kai C
    Mol Ther Oncolytics; 2020 Dec; 19():127-135. PubMed ID: 33145396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NECTIN4 Expression in Extramammary Paget's Disease: Implication of a New Therapeutic Target.
    Murata M; Ito T; Tanaka Y; Kaku-Ito Y; Furue M
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nectin4 is a novel TIGIT ligand which combines checkpoint inhibition and tumor specificity.
    Reches A; Ophir Y; Stein N; Kol I; Isaacson B; Charpak Amikam Y; Elnekave A; Tsukerman P; Kucan Brlic P; Lenac T; Seliger B; Jonjic S; Mandelboim O
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32503945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of a pvrl 4 encoded gene Nectin-4 in metastasis and angiogenesis for tumor relapse.
    Sethy C; Goutam K; Nayak D; Pradhan R; Molla S; Chatterjee S; Rout N; Wyatt MD; Narayan S; Kundu CN
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):245-259. PubMed ID: 31617074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of nectin-4 is associated with ITGB1 and vasculogenic mimicry and may serve as a predictor of poor prognosis in colorectal cancer.
    Zhang J; Liu K; Peng P; Li S; Ye Z; Su Y; Liu S; Qin M; Huang J
    Oncol Lett; 2019 Aug; 18(2):1163-1170. PubMed ID: 31423176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nectin-4 promotes gastric cancer progression via the PI3K/AKT signaling pathway.
    Zhang Y; Chen P; Yin W; Ji Y; Shen Q; Ni Q
    Hum Pathol; 2018 Feb; 72():107-116. PubMed ID: 29208564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic prospects of nectin-4 in cancer: applications and value.
    Li K; Zhou Y; Zang M; Jin X; Li X
    Front Oncol; 2024; 14():1354543. PubMed ID: 38606099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of single-chain variable fragment antibodies targeting the breast cancer tumor marker nectin-4.
    Liu CH; Leu SJ; Lee CH; Lin CY; Wang WC; Tsai BY; Lee YC; Chen CL; Yang YY; Lin LT
    Front Immunol; 2023; 14():1292019. PubMed ID: 38288120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-tumor activity of a recombinant measles virus against canine lung cancer cells.
    Tamura K; Fujiyuki T; Moritoh K; Akimoto H; Iizuka K; Sato H; Asano K; Yoneda M; Kai C
    Sci Rep; 2023 Oct; 13(1):18168. PubMed ID: 37875555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Nectins in HCC and Other Solid Malignant Tumors: Implications for Prognosis and New Treatment Opportunities-A Systematic Review.
    Klekowski J; Zielińska D; Hofman A; Zajdel N; Gajdzis P; Chabowski M
    Cancers (Basel); 2023 Aug; 15(15):. PubMed ID: 37568798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment.
    Chang HK; Park YH; Choi JA; Kim JW; Kim J; Kim HS; Lee HN; Cho H; Chung JY; Kim JH
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.